Edwards names a new CFO
ποΈ Doretta Mistras has been appointed as the new Chief Financial Officer for Edwards Lifesciences, with her appointment taking effect at the end of May 2026.
π She succeeds Scott Ullem, who is stepping down from his role after serving as CFO for over a decade since joining in 2014.
π Scott Ullem announced his departure in October 2025 and will continue to serve Edwards as a strategic advisor during the transition.
πΌ Prior to joining Edwards, Mistras held the position of CFO at pharmaceutical company Viatris since March 2024.
π° During her tenure at Viatris, she led the global finance organization and oversaw financial planning, reporting, and operational finance.
π¦ Before leading finance at a pharma firm, Mistras served as a managing director in healthcare investment banking at Citigroup Global Markets.
βοΈ Her early career included holding senior leadership roles in healthcare investment banking at Goldman Sachs.
π₯ Edwards highlights Mistras' decades of experience in healthcare leadership across corporate finance, strategy, and investor relations.
π€ CEO Bernard Zovighian expressed pleasure at welcoming Mistras to the company to execute its differentiated strategy.
π The new CFO's experience is expected to help Edwards invest in innovation while delivering durable financial results and long-term value.
π Edwards publicly thanked Scott Ullem for his outstanding leadership, partnership, and impact on strengthening the company strategically and financially.
π The transition is designed to reflect discipline and continuity, a core aspect of Edwards' approach to leadership over time.
- Doretta Mistras brings decades of healthcare leadership experience across corporate finance, strategy, and investor relations to the role.
- She previously led global finance, planning, reporting, and operational finance at Viatris since March 2024, demonstrating significant financial management capability.
- Her background includes senior leadership roles at Goldman Sachs and Citigroup Global Markets in healthcare investment banking.
- CEO Bernard Zovighian stated that her broad experience will be instrumental as Edwards executes its differentiated strategy to deliver durable financial results.
- The company aims to use this leadership continuity to invest in innovation and deliver long-term value to shareholders and the broader healthcare ecosystem.
- Scott Ullem, who served as CFO since 2014 for over a decade, will continue as a strategic advisor to ensure disciplined transition and continuity.
- CFO Scott Ullem is departing after more than a decade in the role, joining in 2014, which could introduce execution risks during the transition period.
- The new CFO, Doretta Mistras, succeeds Ullem at the end of May 2026, following his announcement to depart in October 2025, creating a significant leadership change with potential operational instability.
- CEO Bernard Zovighian's statement highlights the need to 'execute our differentiated strategy' and deliver results, suggesting current financial performance may require new leadership support to stabilize.